Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Healthequity (HQY) EBIT Margin (2016 - 2026)

Healthequity (HQY) has 13 years of EBIT Margin data on record, last reported at 24.43% in Q4 2025.

  • For Q4 2025, EBIT Margin rose 1789.0% year-over-year to 24.43%; the TTM value through Oct 2025 reached 22.74%, up 891.0%, while the annual FY2025 figure was 13.53%, 176.0% up from the prior year.
  • EBIT Margin reached 24.43% in Q4 2025 per HQY's latest filing, down from 27.5% in the prior quarter.
  • Across five years, EBIT Margin topped out at 27.5% in Q3 2025 and bottomed at 13.4% in Q1 2022.
  • Average EBIT Margin over 5 years is 8.45%, with a median of 8.01% recorded in 2024.
  • Peak YoY movement for EBIT Margin: crashed -1256bps in 2022, then soared 1906bps in 2023.
  • A 5-year view of EBIT Margin shows it stood at 0.2% in 2021, then skyrocketed by 1361bps to 2.56% in 2022, then surged by 383bps to 12.4% in 2023, then crashed by -47bps to 6.53% in 2024, then soared by 274bps to 24.43% in 2025.
  • Per Business Quant database, its latest 3 readings for EBIT Margin were 24.43% in Q4 2025, 27.5% in Q3 2025, and 25.11% in Q2 2025.